C07J 13/005
Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double
Official title: {with double bond in position 16 (17)}
C07J13/005 (Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double) appears on 157 US grants and 59 published applications in this corpus.
Search patents in C07J- Granted patents
- 157
- Published applications
- 59
- Assignees
- 77
- Inventors
- 307
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 8 | 0 |
| 1979 | 6 | 0 |
| 1980 | 7 | 0 |
| 1981 | 4 | 0 |
| 1982 | 6 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 9 | 0 |
| 1999 | 9 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 3 |
| 2003 | 2 | 1 |
| 2004 | 1 | 3 |
| 2005 | 2 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 2 | 4 |
| 2014 | 0 | 8 |
| 2015 | 3 | 1 |
| 2016 | 1 | 4 |
| 2017 | 0 | 3 |
| 2018 | 3 | 3 |
| 2019 | 5 | 8 |
| 2020 | 3 | 2 |
| 2021 | 4 | 2 |
| 2022 | 1 | 5 |
| 2023 | 2 | 3 |
| 2024 | 2 | 3 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neuroactive steroids and methods of use thereof5 May 2026US 12,617,814 B2Sage Therapeutics, Inc.
- Sterols as novel immunomodulatory agents and their use as vaccine adjuvants25 Nov 2025US 12,478,671 B2Ohio State Innovation Foundation
- Oxysterols and methods of use thereof29 Oct 2024US 12,129,276 B2Sage Therapeutics, Inc.
- Neuroactive steroids and methods of use thereof20 Feb 2024US 11,905,309 B2Sage Therapeutics, Inc.
- Oxysterols and methods of use thereof22 Aug 2023US 11,732,000 B2Sage Therapeutics, Inc.
- Sterols as novel immunomodulatory agents and their use as vaccine adjuvants26 Feb 2026US 2026/0053912 A1Ohio State Innovation Foundation
- Method for preparing abiraterone acetate and intermediate thereof25 Sep 2025US 2025/0296952 A1Aurisco Pharmaceutical Co., Ltd.
- Oxysterols and methods of use thereof14 Aug 2025US 2025/0257091 A1Sage Therapeutics, Inc.
- Neuroactive steroids and methods of use thereof29 Aug 2024US 2024/0287125 A1Sage Therapeutics, Inc.
- Oxysterols and methods of use thereof25 Apr 2024US 2024/0132535 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series70US 5,232,917 AUniversity of Southern California · 1993
- Chemical compounds60US 4,192,871 AGlaxo Laboratories Limited · 1980
- 17-substituted steroids useful in cancer treatment56US 5,604,213 ABritish Technology Group Limited · 1997
- 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof54US 4,559,332 ACiba-Geigy Corporation · 1985
- 11 .beta.-substituted progesterone analogs47US 4,954,490 AResearch Triangle Institute · 1990